BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21163066)

  • 1. [Increased level of Th17 cells in peripheral blood correlates with the development of hepatocellular carcinoma].
    Wang WW; Wang ZM; Liu YY; Qin YH; Shen Q
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):757-61. PubMed ID: 21163066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
    Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
    Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression.
    Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X
    J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of Th17 cells in patients with gastric cancer.
    Zhang B; Rong G; Wei H; Zhang M; Bi J; Ma L; Xue X; Wei G; Liu X; Fang G
    Biochem Biophys Res Commun; 2008 Sep; 374(3):533-7. PubMed ID: 18655770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
    Shi M; Zhang Y; Zhong C; Lin XJ; Zhang CQ; Li JQ
    Ai Zheng; 2008 Jan; 27(1):83-7. PubMed ID: 18184471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of glypican-3 mRNA expression in hepatocellular carcinoma tissues and peripheral blood cells].
    Li BD; Zhao QC; Zhu YT; Zhang FQ; Dou KF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):458-62. PubMed ID: 16772080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effects of different clinicopathologic variables on serum protein fingerprint in hepatocellular carcinoma patients].
    Huang C; Fan J; Zhou J; Liu YK; Cui JF
    Zhonghua Wai Ke Za Zhi; 2006 Apr; 44(7):445-9. PubMed ID: 16772076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its corresponding peripheral blood expression in patients with hepatocellular carcinoma.
    Lu Y; Wu LQ; Lü ZH; Wang XJ; Yang JY
    Chin Med J (Engl); 2007 Jun; 120(12):1042-6. PubMed ID: 17637219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction.
    Liu Y; Wu MC; Qian GX; Zhang BH
    Hepatobiliary Pancreat Dis Int; 2002 Feb; 1(1):72-6. PubMed ID: 14607627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and clinical significance of metastasis-associated in colon cancer 1 (MACC1) in HBV-related hepatocellular carcinoma].
    Chang XJ; Wang CP; Qu JH; Lu YY; Chen Y; Bai WL; Gao XD; Hao LY; Xu GL; Wang H; Yang YP
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):748-52. PubMed ID: 23291068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.
    Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K
    Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Correlation of NY-ESO-1 gene and protein expression to metastasis and clinicopathologic features of hepatocellular carcinoma].
    Zhang WM; Xiao G; Xie D; Zhang M; Guo AL; Wen JM
    Ai Zheng; 2005 May; 24(5):622-6. PubMed ID: 15890110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of tissue factor in hepatocellular carcinoma genesis, invasion and metastasis.
    Zhou Q; Huang T; Wang YF; Zhou XB; Liang LJ; Peng BG
    Chin Med J (Engl); 2011 Nov; 124(22):3746-51. PubMed ID: 22340235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of liver cells in peripheral blood of patients with advanced-stage hepatocellular carcinoma.
    Kar S; Carr BI
    Hepatology; 1995 Feb; 21(2):403-7. PubMed ID: 7843713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity.
    Liu Z; Yadav PK; Xu X; Su J; Chen C; Tang M; Lin H; Yu J; Qian J; Yang PC; Wang X
    J Leukoc Biol; 2011 Apr; 89(4):597-606. PubMed ID: 21227898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-17 Producing Cells and RORγt mRNA Transcriptional Factor in Cirrhotic and HCC Egyptian Patients.
    El Bassuoni MA; Soliman MA; El Megeed NA; Al Gazar A
    Egypt J Immunol; 2015; 22(1):59-68. PubMed ID: 26415373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.